Symbols

INMD

InMode·NASDAQ

--(--)

INMD fundamentals

INMD Q4 2025 Earnings

InMode (INMD) released its earnings on Feb 10, 2026: revenue was 103.85M (YoY +6.13%), beat estimates; EPS was 0.46 (YoY +9.52%), beat estimates.

Revenue / YoY

103.85M

+6.13%

EPS / YoY

0.46

+9.52%

Report date

Feb 10, 2026

INMD Earnings Call Summary for Q4,2025

Revenue Stabilization: 2025 revenue down 6% YoY to $370.5M, with encouraging signs in consumables (+22% of revenue) and Europe (+38% Q4 sales)
New Product Pipeline: 2026 launches of pico laser and Morpheus/Erbium combo device expected to drive growth
Margin Headwinds: 2026 gross margin target of 75-77% due to lower-margin laser products
Strategic Alternatives: Board exploring options after $508M share buyback
Clinical Pipeline: Dry eye indication under FDA review with potential 2027 approval

Earnings

EPS

Revenue

Revenue & Expenses

INMD has released its 2025 Q4 earnings report, with revenue of 103.85M, reflecting a YoY change of 6.13%, and net profit of 27.02M, showing a YoY change of -67.35%. The Sankey diagram below clearly presents INMD's revenue sources and cost distribution.

Key Indicators

InMode (INMD) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

InMode (INMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

InMode (INMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

InMode (INMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown